by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersMaximus Health, Inc. dba Maximus

All Warning Letters

Maximus Health, Inc. dba Maximus

Warning LetterOpen

Maximus Health, Inc. dba Maximus, 2219 Main Street, #347 Santa Monica , CA 90405 United StatesIssued Jun 8, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations2

Issue DateJun 8, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Maximus Health, Inc. dba Maximus
Location: Maximus Health, Inc. dba Maximus, 2219 Main Street, #347 Santa Monica , CA 90405 United States
FEI Number: N/A
Country: United States
Issue Date: June 08, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

False & Misleading Claims/Misbranded (Telehealth)

Maximus Health, Inc. dba Maximus FDA Warning Letter, June 8, 2026